CLINICAL_TRIALS
trial_result
· 2025-09-22
Clinical Trial Update: A Heart Disease Study of Semaglutide in Patients With Type 2 Diabetes [Phase 3]
Summary
Phase 3 trial evaluating semaglutide for cardiovascular outcomes in patients with type 2 diabetes; results have been posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Novo Nordisk A/S | Conditions: Diabetes Mellitus, Type 2 | Phase 3 | Status: COMPLETED | Results posted: 2025-09-22